Design Therapeutics, Inc.DSGNNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P17
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -7.98% |
| Q3 2025 | -7.30% |
| Q2 2025 | 2.35% |
| Q1 2025 | 26.49% |
| Q4 2024 | 2.37% |
| Q3 2024 | 14.58% |
| Q2 2024 | 7.32% |
| Q1 2024 | -12.30% |
| Q4 2023 | -16.93% |
| Q3 2023 | -22.31% |
| Q2 2023 | 8.48% |
| Q1 2023 | 10.35% |
| Q4 2022 | -0.34% |
| Q3 2022 | 26.64% |
| Q2 2022 | 28.95% |
| Q1 2022 | 19.38% |
| Q4 2021 | -14.08% |
| Q3 2021 | 69.86% |
| Q2 2021 | 29.73% |
| Q1 2021 | 43.09% |
| Q4 2020 | 41.48% |
| Q3 2020 | 80.40% |
| Q2 2020 | 181.43% |
| Q1 2020 | 0.00% |